PCN81 Economic Evaluation of First-LINE Atezolizumab for Extensive-STAGE SMALL-Cell LUNG Cancer: The Difference between the Standard Parametric MODEL and the Mixture Cure MODEL M. Rui,Y. Wang,L. Yang, X.T. Wang, Y. Shang,A.X. Ma,H.C. LiVALUE IN HEALTH（2021）引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
